Aging blood vessel study pulled before it even started
NCT ID NCT04344873
First seen Jan 12, 2026 · Last updated May 14, 2026 · Updated 23 times
Summary
This study was designed to see if a drug called abatacept could improve blood vessel function in older adults by targeting immune cells called T cells. It planned to enroll people aged 55-75 without major health problems. However, the study was withdrawn before any volunteers were enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATION are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.